Page last updated: 2024-12-11

linolenyl alcohol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

linolenyl alcohol: RN given refers to (Z,Z,Z)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(9Z,12Z,15Z)-octadecatrien-1-ol : A long chain fatty primary alcohol that is octadecanol containing three double bonds located at positions 9, 12 and 15. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6436081
CHEBI ID77474
SCHEMBL ID59807
MeSH IDM0114469

Synonyms (23)

Synonym
506-44-5
(9z,12z,15z)-9,12,15-octadecatrien-1-ol
linolenyl alcohol
(9z,12z,15z)-octadeca-9,12,15-trien-1-ol
einecs 208-039-7
yc8dmo65r7 ,
unii-yc8dmo65r7
9,12,15-octadecatrien-1-ol, (9z,12z,15z)-
SCHEMBL59807
linolenic alcohol
(z,z,z)-9,12,15-octadecatrien-1-ol
all-cis-9,12,15-octadecatrien-1-ol
cis,cis,cis-9,12,15-octadecatrien-1-ol
9,12,15-octadecatrien-1-ol, (z,z,z)-
linolenyl alcohol [usp-rs]
cis,cis,cis-9,12,15-octadecatrienol
(9z,12z,15z)-octadecatrienyl alcohol
(9z,12z,15z)-1-octadecatrienol
(9z,12z,15z)-octadecatrien-1-ol
CHEBI:77474
(9e,12e,15e)-9,12,15-octadecatrien-1-ol #
Q27147009
DTXSID80880766

Research Excerpts

Effects

ExcerptReferenceRelevance
"Linolenyl alcohol has been shown to inhibit the in vitro growth of several species of gram-positive bacteria. "( Use of lipids to potentiate the antibacterial activity of aminoglycosides.
Connamacher, R; Gilbertson, JR; Langkamp, HH; Platt, D, 1984
)
1.71
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
long-chain primary fatty alcoholA long-chain fatty alcohol in which the hydroxy group is attached to a methylene (CH2) group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.12 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]